Vilazodone for the Treatment of Paternal Post Natal Depression

Despite its common occurrence affecting up to 10%-14% of new fathers 6 to 12 months after a child birth, paternal postnatal (PPND) is not usually recognized or treated. Like major depressive disorder (MDD) the treatment of PPND may require the combination of psychopharmacology, psychotherapy, social and spiritualintervention.

Most clinical guidelines recommend cognitive behavioral therapy (CBT) as the psychotherapy of choice alone or combined with selective serotonin reuptake inhibitors (SSRIs) or serotonin norepinephrine reuptake inhibitors (SNRIs) for the treatment of MDD. The presence of maternal postpartum depression (MPPD)and marital discord are significantly correlated with PPND. This report describes a case of a 30 year-old new father who developed PPND in the absence of both MPPD and marital discord who did not tolerate treatment with the SSRI fluoxetine and the SNRI venlafaxine but had a favorable response to vilazodone the first-of-class of antidepressants classified as a serotonin partial agonist reuptake inhibitor (SPARI).  Read more>>>>>>>>>>>>>